What Is NAD+? How It Works + The Complete Stack Protocol

The human body runs on a currency called ATP, which stands for adenosine triphosphate, and it is the single molecule your cells use to do every piece of biological work imaginable, from squeezing a muscle fiber to sending a signal down a nerve to patching a torn strand of DNA. What makes this system remarkable and also fragile is that your body stores almost none of it, keeping only about 100 grams on hand at any moment, which is enough to power just a few seconds of activity, so your cells are forced to manufacture and recycle ATP continuously throughout every hour of every day.

A moderately active person will cycle through roughly their entire body weight in ATP over the course of a single day, which gives you a sense of how relentless this production demand actually is.

How Your Cells Actually Build ATP

Your body runs three distinct manufacturing processes to keep up with that demand, and understanding them in order matters because NAD+ sits right in the middle of the most important one.

The first process is something called glycolysis, which is the breakdown of glucose that happens outside the mitochondria in the fluid of the cell itself. Glycolysis is extremely fast, operating in milliseconds, and it is the pathway your body leans on during the first roughly ten seconds of intense anaerobic effort like a heavy squat or a short sprint. The tradeoff is that glycolysis produces lactic acid as a waste product, which is the molecule responsible for that familiar burning sensation in your muscles, and because of that accumulation it simply cannot be sustained for long periods.

The second process is something called the Krebs cycle, which operates inside the mitochondria and takes the products of glycolysis and fully breaks them down through a series of chemical reactions. The Krebs cycle is where most of your NADH gets generated, and NADH is essentially a carrier molecule, a shuttle that picks up high-energy electrons and transports them to the next stage.

That third stage is something called the electron transport chain, which sits on the inner membrane of the mitochondria and is responsible for roughly 90 percent of all the ATP your body makes. The electron transport chain takes the electrons delivered by NADH, uses them to pump protons across the inner mitochondrial membrane, and harnesses the flow of those protons to drive ATP synthesis, so the whole sequence from food to Krebs cycle to electron transport chain is really one long connected energy-harvesting process.

Where NAD+ Fits Into This System

NAD+ is the oxidized form of this carrier molecule, meaning it is the empty version waiting to pick up electrons, and NADH is the loaded version carrying those electrons toward the electron transport chain. So when the Krebs cycle generates NADH, it is converting NAD+ into its electron-carrying form, and when the electron transport chain offloads those electrons to make ATP, NADH gives up its cargo and becomes NAD+ again so it can go pick up more electrons, and this cycle repeats thousands of times per day inside every cell in your body.

The ratio of NAD+ to NADH in healthy cells is approximately 700 to 1, meaning there is a large reservoir of the oxidized form ready to accept electrons at any moment, and this ratio is not just a bookkeeping detail because it directly reflects how efficiently your cells are producing energy. An abundance of NAD+ means electrons move freely through the system and ATP gets made quickly and cleanly, while a scarcity of NAD+ creates a bottleneck where the entire downstream process slows down and cellular stress begins to accumulate.

Why NAD+ Declines With Age

NAD+ levels fall by roughly 50 percent every 20 years, so a person at 40 is operating with approximately half the NAD+ they had at 20, and this happens through three overlapping mechanisms.

First, certain enzymes that consume NAD+ become more active or less efficient with age, so the molecule gets used up faster than it can be replaced. Second, the enzyme primarily responsible for producing NAD+ through what is called the salvage pathway is something called NAMPT, which stands for nicotinamide phosphoribosyltransferase, and NAMPT activity itself declines with aging, so the body's main recycling mechanism weakens precisely when it is most needed. Third, mitochondria accumulate damage over time, and damaged mitochondria cannot recycle NAD+ effectively because the machinery that processes it has degraded.

The downstream consequences of this decline extend well beyond fatigue, because NAD+ is connected to cellular repair processes, inflammation regulation, and gene expression pathways that govern how cells respond to stress, and lower NAD+ has been associated with conditions including type 2 diabetes, cardiovascular disease, neurodegeneration, and metabolic syndrome.

The Three Pathways Your Body Uses to Make NAD+

Your body synthesizes NAD+ through three distinct routes, and every supplement or intervention you have heard about feeds into one of them.

The first is something called the de novo pathway, which builds NAD+ from scratch starting with an amino acid called tryptophan. This pathway is slow, energetically costly, and primarily occurs in the liver, so it is not a practical target for supplementation.

The second is something called the Preiss-Handler pathway, which converts niacin, the form of vitamin B3 found in food and supplements, directly into NAD+. Niacin supplementation feeding this pathway is inexpensive and well-documented, but it causes something called a niacin flush, which is a wave of redness, warmth, and itching across the skin that typically lasts 20 to 30 minutes after taking the supplement, and many people find this sensation intolerable enough to discontinue.

Two compounds you have likely heard promoted as alternatives are something called NMN, which stands for nicotinamide mononucleotide, and something called NR, which stands for nicotinamide riboside. NMN is chemically one step away from becoming NAD+ directly, while NR gets converted to NMN inside the cell and then to NAD+. Both avoid the flush, but both are substantially more expensive than niacin, and recent research suggests that most oral NMN and NR taken by mouth gets converted to niacin by gut bacteria before absorption anyway, meaning the consumer is essentially paying a large premium for a compound that the digestive system transforms into the cheap version before it ever reaches the bloodstream.

For people who cannot tolerate the niacin flush, there is another option in the form of direct intravenous or injectable NAD+, which bypasses gut conversion entirely and delivers the molecule straight into circulation without requiring the body to synthesize it through any of these pathways.

The third pathway is something called the salvage pathway, and it accounts for roughly 80 percent of all NAD+ production in the body. This pathway recycles nicotinamide, which is the byproduct produced whenever NAD+ gets consumed in a cellular reaction, and converts it back into usable NAD+ through two enzymatic steps with NAMPT as the key rate-limiting enzyme.

The Role of 5-Amino-1MQ and the NNMT Connection

There is a compound called 5-amino-1MQ that works not by adding NAD+ or its precursors but by blocking a specific drain on the system. An enzyme called NNMT, which stands for nicotinamide N-methyltransferase, normally takes nicotinamide and converts it into a waste product that gets excreted, so it is essentially pulling raw material away from the salvage pathway before NAMPT can use it to rebuild NAD+. 5-amino-1MQ inhibits NNMT, which means more nicotinamide remains available to feed back into NAD+ production through the salvage pathway rather than being lost as waste.

Why Fixing the Mitochondria Matters Before Adding Fuel

There is a critical limitation to all NAD+ supplementation that often goes unaddressed, which is that converting NAD+ precursors into usable NAD+ actually requires ATP to power the enzymatic reactions involved. If the mitochondria are damaged enough that they cannot produce ATP efficiently, they also cannot process the precursors you are giving them, which is why some people take NMN or NR or even receive NAD+ injections and feel no discernible effect.

This is where a peptide called SS-31 becomes relevant, because SS-31 is designed to stabilize the inner mitochondrial membrane, which is the specific structure where the electron transport chain operates and where damage accumulates over time. By stabilizing that membrane, SS-31 theoretically allows damaged mitochondria to resume more efficient ATP production, which then creates the conditions in which NAD+ precursors can actually be processed and used.

Once mitochondrial function is restored to a reasonable baseline, a second peptide called MOTS-c works to optimize how efficiently the repaired mitochondria operate. MOTS-c activates something called AMPK, which stands for AMP-activated protein kinase and functions as a cellular sensor that detects low energy states and responds by increasing metabolic efficiency, improving glucose utilization, and signaling the cell to prioritize energy production.

Creatine and the ATP Storage Problem

Even with optimal NAD+ levels and healthy mitochondria, there is still the fundamental issue that mitochondria cannot produce ATP instantaneously and cells need bursts of energy faster than biosynthesis can supply. This is where creatine fits into the picture, because creatine helps the body produce something called phosphocreatine, which is a molecule that stores a high-energy phosphate group right next to the muscle fiber so it can be transferred to ADP to regenerate ATP in fractions of a second without waiting for the mitochondria. Beyond that rapid energy buffering role, creatine also supports mitochondrial biogenesis, which is the process by which cells grow new mitochondria, so it contributes to the overall capacity of the system rather than just its speed.

A Two-Phase Protocol and the Cycling Consideration

The logical structure of combining these compounds follows a repair-before-optimization sequence. During an initial phase lasting roughly eight weeks, the goal is to address mitochondrial damage and establish NAD+ production by using SS-31 to stabilize the mitochondrial membrane, niacin or injectable NAD+ to supply substrate, 5-amino-1MQ to reduce nicotinamide waste, and creatine to support the ATP system throughout. In a subsequent optimization phase, SS-31 is replaced by MOTS-c while the other compounds continue, shifting the focus from repair toward efficiency.

One important consideration that often gets overlooked is that chronic supplementation with NAD+ precursors can suppress the body's own production of NAMPT, meaning the salvage pathway weakens during extended supplementation and may leave a person in a worse position than before if they stop abruptly after long-term use. Cycling the supplementation on a pattern of roughly eight to twelve weeks on followed by four to eight weeks off allows the natural enzyme activity to recover, and this is supported by the well-documented observation that exercise alone increases NAMPT expression by over 100 percent and raises muscle NAD+ by a comparable amount, reinforcing that training, nutrition, and sleep remain the most powerful tools for maintaining this system before any supplementation is considered.

---

References

1. Martínez-Reyes I, Cardona LR, Kong H et al.. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature. 2020. Source
2. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl. 1997. Source
3. Deng S, Beatty W, Sibley LD. Assessing the function of the alternative electron transport chain in the Cryptosporidium parvum mitosome. mBio. 2025. Source
4. Zhang H. Hyperpolarized sodium 1-13Cpyruvate. . 2004. Source
5. Lu D, Grant M, Lim BL. NADH and NADPH in plants and mammals. Mol Plant. 2025. Source
6. Bunik VI. 2-Oxo acid dehydrogenase complexes in redox regulation. Eur J Biochem. 2003. Source
7. Smits MAJ, Schomakers BV, van Weeghel M et al.. Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction. Hum Reprod. 2023. Source
8. McCully KS. Review: Chemical Pathology of Homocysteine VI. Aging, Cellular Senescence, and Mitochondrial Dysfunction. Ann Clin Lab Sci. 2018. Source
9. Shim DW, Cho HJ, Hwang I et al.. Intracellular NAD+ Depletion Confers a Priming Signal for NLRP3 Inflammasome Activation. Front Immunol. 2021. Source
10. Maldonado EN. VDAC-Tubulin, an Anti-Warburg Pro-Oxidant Switch. Front Oncol. 2017. Source
11. Cruz-Ojeda P, Navarro-Villarán E, Fuertes-Agudo M et al.. Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer cells. Free Radic Biol Med. 2025. Source
12. Fang D, Maldonado EN. VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation. Adv Cancer Res. 2018. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness